Table 2.
The highest fold rise in MFI or DPP values was used to determine the positivity
| Serum source | Adsa | H5 (Indo) | pH1 (pH1 or pH1/H3)b | ||
|---|---|---|---|---|---|
| MAGPIX | DPP | MAGPIX | DPP | ||
| H5 vaccineesc | N | 100% (13/13) d | 92% (12/13) | 0% (0/13) | 0% (0/13) |
| H5 vaccineesc | Y | 100% (13/13) | 92% (12/13) | 0% (0/13) | 0% (0/13) |
| pH1N1 exposed personse | N | 3% (1/36) | 11% (4/36)f | 97% (35/36) d | 67% (24/36) g |
| pH1N1 exposed personse | Y | 0% (0/36) | 3% (1/36)f | 100% (36/36) | 86% (31/36) g |
a
Serum samples were either mock (N) or adsorbed (Y) with ectodomain pH1/H3 rHA‐conjugated latex beads.
b
GH HA1 of pH1 and GH HA1 of pH1/H3 were used in MAGPIX and DPP, respectively.
c
Paired sera were collected from 13 persons vaccinated with ASO3‐adjuvanted A/Indonesia/05/2005 (H5N1).
d
Percent sensitivities for homologous HA subtype are highlighted in bold.
e
Paired sera were collected from 36 persons infected with pH1N1 viruses or vaccinated with split monovalent A/California/07/2009 (pH1N1).
f
P=.357.
g
P=.052.